Railway Pension Investments LTD Incyte Corp Transaction History

Railway Pension Investments LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 22, 2020	SELL	$63.18 - $85.97 $1.61 Million - $2.19 Million	-25,500 Closed	0 $0
Q4 2019 Feb 03, 2020	SELL	$73.04 - $95.72 $58,432 - $76,576	-800 Reduced 3.04%	25,500 $0
Q3 2019 Oct 24, 2019	BUY	$72.82 - $86.52 $29,127 - $34,608	400 Added 1.54%	26,300 $1.95 Million
Q2 2019 Oct 03, 2019	BUY	$73.52 - $88.7 $1.9 Million - $2.3 Million	25,900 New	25,900 $2.2 Million
Q2 2019 Jul 16, 2019	SELL	$73.52 - $88.7 $1.71 Million - $2.06 Million	-23,200 Closed	0 $0
Q1 2019 Oct 03, 2019	BUY	$63.56 - $88.17 $1.47 Million - $2.05 Million	23,200 New	23,200 $2 Million

627

197M

766K

476K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Railway Pension Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Railway Pension Investments LTD with notifications on news.